THE COMMISSION OF THE EUROPEAN COMMUNITIES,
Having regard to the Treaty establishing the European Community,
Having regard to Regulation (EC) No 999/2001 of the European Parliament and of the Council of 22 May 2001 laying down rules for the prevention, control and eradication of certain transmissible spongiform encephalopathies(1), and in particular Article 5(2) thereof,
Whereas:
(1) Regulation (EC) No 999/2001 lays down rules for the prevention, control and eradication of transmissible spongiform encephalopathies (TSEs) in animals. According to Article 1 of that Regulation it applies to the production and placing on the market of live animals and products of animal origin. For that purpose, the bovine spongiform encephalopathy (BSE) status of Member States or third countries or regions thereof (countries or regions) is to be determined by classification into one of three categories depending on the BSE risk as laid down in Article 5(1) of that Regulation.
(2) The objective of categorising countries or regions according to their BSE risk is to establish trade rules for each BSE risk category in order to provide the necessary guarantees for protecting animal and public health.
(3) Annex VIII to Regulation (EC) No 999/2001 sets out the rules for intra-Community trade and Annex IX to that Regulation sets out the rules relating to imports into the Community. They are based on the rules laid down in the Terrestrial Animal Health Code of the World Organisation for Animal Health (OIE).
(4) The OIE plays a leading role in the categorisation of countries or regions according to their BSE risk.
(5) During the OIE General Session in May 2007, a Resolution was adopted relating to the BSE status of different countries. Pending a final conclusion on the BSE risk status of the Member States and taking into account the harmonised stringent BSE protective measures applied within the Community, the Member States should be provisionally recognised as countries with a controlled BSE risk.
(6) In addition, awaiting the final conclusion on the BSE risk status concerning Norway and Iceland and taking into account the results of the most recent risk assessments concerning those third countries, they should be provisionally recognised as countries with a controlled BSE risk.
(7) Pursuant to Article 23 of Regulation (EC) No 999/2001, transitional measures were taken for a period ending on 1 July 2007. Those measures are to cease to apply immediately following the date of adoption of a decision on classification in accordance with Article 5 of that Regulation. A decision should therefore be taken to classify countries or regions according to their BSE risk before that date.
(8) The measures provided for in this Decision are in accordance with the opinion of the Standing Committee on the Food Chain and Animal Health,
HAS ADOPTED THIS DECISION:
[F1(1)]The BSE status of countries or regions according to their BSE risk is set out in the Annex.
[F2(2)However, the official United Kingdom BSE status for England, Northern Ireland, Scotland and Wales is categorised by reference to the website of the OIE, as amended from time to time.]
Textual Amendments
F1Art. 1 renumbered as Art. 1(1) (31.12.2020) by The Transmissible Spongiform Encephalopathies and Animal By-Products (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/170), regs. 1, 3(2)(a); 2020 c. 1, Sch. 5 para. 1(1)
F2Art. 1(2) inserted (31.12.2020) by The Transmissible Spongiform Encephalopathies and Animal By-Products (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/170), regs. 1, 3(2)(b); 2020 c. 1, Sch. 5 para. 1(1)
This Decision shall apply from 1 July 2007.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Textual Amendments
F3Art. 3 omitted (31.12.2020) by virtue of The Transmissible Spongiform Encephalopathies and Animal By-Products (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/170), regs. 1, 3(3); 2020 c. 1, Sch. 5 para. 1(1)
Textual Amendments
Belgium
Bulgaria
Czech Republic
Denmark
Germany
Estonia
Croatia
Italy
Cyprus
Latvia
Lithuania
Luxembourg
Hungary
Malta
Netherlands
Austria
Poland
Portugal
Romania
Slovenia
Slovakia
Spain
Finland
Sweden
Textual Amendments
F6Words in Annex Pt. A omitted (31.12.2020) by virtue of The Transmissible Spongiform Encephalopathies and Animal By-Products (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/170), regs. 1, 3(4)(a)(ii); 2020 c. 1, Sch. 5 para. 1(1)
Textual Amendments
F5Words in Annex Pt. A omitted (31.12.2020) by virtue of The Transmissible Spongiform Encephalopathies and Animal By-Products (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/170), regs. 1, 3(4)(a)(i); 2020 c. 1, Sch. 5 para. 1(1)
Iceland
Liechtenstein
Norway
Switzerland
Argentina
Australia
Brazil
Chile
Colombia
Costa Rica
India
Israel
Japan
Namibia
New Zealand
Panama
Paraguay
Peru
Singapore
United States
Uruguay
Textual Amendments
Ireland
Greece
France
F8...
Textual Amendments
F8Words in Annex Pt. B omitted (31.12.2020) by virtue of The Transmissible Spongiform Encephalopathies and Animal By-Products (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/170), regs. 1, 3(4)(b); 2020 c. 1, Sch. 5 para. 1(1)
Canada
Mexico
Nicaragua
South Korea
Taiwan
Countries or regions not listed in points A or B [F9, other than the regions of the constituent nations of the British Islands, which have an official BSE risk status determined by their categorisation by the OIE].]
Textual Amendments
F9Words in Annex Pt. C inserted (31.12.2020) by The Transmissible Spongiform Encephalopathies and Animal By-Products (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/170), regs. 1, 3(4)(c) (as amended by S.I. 2020/1388, regs. 1(2)(a), 20(3)); 2020 c. 1, Sch. 5 para. 1(1)
OJ L 147, 31.5.2001, p. 1. Regulation as last amended by Regulation (EC) No 1923/2006 (OJ L 404, 30.12.2006, p. 1).
[F4 [F7as referred to in Article 135 of the Stabilisation and Association Agreement between the European Communities and their Member States of the one part, and the Republic of Serbia, of the other part ( OJ L 278, 18.10.2013, p. 16 ).] ]